AKAP13 Protein (AA 359-587)
Recombinant AKAP13 protein expressed in Escherichia coli (E. coli).
Catalog No. ABIN7887814
$1,961.14
Plus shipping costs $50.00, if applicable $20.00 dry ice
500 μg
Shipping to:
United States
Delivery in 11 to 22 Business Days
Quick Overview for AKAP13 Protein (AA 359-587) (ABIN7887814)
Target
AKAP13
(A Kinase (PRKA) Anchor Protein 13 (AKAP13))
Protein Type
Recombinant
Origin
Human
Source
Escherichia coli (E. coli)
-
-
Protein Characteristics
- AA 359-587
-
Purpose
- Recombinant Human A-kinase anchor protein 13
-
Characteristics
- MADE TO ORDER | Recombinant Human A-kinase anchor protein 13 is produced by E.coli expression system and the target gene encoding I359-V587 is expressed.
-
Sterility
- 0.2 μm filtered
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions
-
A Kinase (PRKA) Anchor Protein 13 (AKAP13) (AA 2-161) protein (His-IF2DI Tag)
AKAP13 Origin: Human Host: Escherichia coli (E. coli) Recombinant Greater than 90 % as determined by SDS-PAGE. ELISA, WB
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a 0.2 um filtered solution of 500 mM PBS, 300 mM NaCl, 10 % Glycerol, pH 7.1
-
Handling Advice
- minimize freeze-thaw cycles,handle under sterile conditions after opening
-
Storage
- -80 °C
-
Storage Comment
- Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening.Please minimize freeze-thaw cycles.
-
Expiry Date
- 6 months
-
-
- AKAP13 (A Kinase (PRKA) Anchor Protein 13 (AKAP13))
-
Alternative Name
- AKAP-13
-
Background
- Alternative Names: AKAP-13, AKAP-Lbc, Breast cancer nuclear receptor-binding auxiliary protein, Guanine nucleotide exchange factor Lbc, Human thyroid-anchoring protein 31, Lymphoid blast crisis oncogene, LBC oncogene
-
UniProt
- Q12802
-
Pathways
- Neurotrophin Signaling Pathway
Target
-
You are here:
